2 completed, 1 withdrawn. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
Follow Sodium Fusidate: new trials by email Literature Review of Sodium Fusidate trials Research Report on Sodium Fusidate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations Sodium Fusidate, Placebo - Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | Phase 2 | Withdrawn | Aceragen | 2023-02-10 | 2023-07-19 | |
| Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections sodium fusidate - Refractory Bone or Joint Infections | Phase 2 / Phase 3 | Completed | Arrevus Inc. | 30 | 2015-12-01 | 2020-01-30 |
| Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections sodium fusidate, linezolid - Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Completed | Arrevus Inc. | 716 | 2015-11-01 | 2019-04-19 |
Cellulitis (1) · Cystic Fibrosis (1) · Osteomyelitis (1)
Arrevus Inc. (2) · Aceragen (1)
United States (3) · Puerto Rico (1)
Richard Pushkin, MD (1) · Robert Dobbins, MD, PhD (1)